Search

everythinglearnresearchcommunity

for

Search:↓

The FDA rejected a testosterone drug again due to safety concerns.

Young HS patients often have other physical and mental health issues, and research on HS covers a wide range of topics including genetics, triggers, treatments, and the need for more data.

Syphilitic alopecia is a rare hair loss condition in secondary syphilis that looks similar to another condition but can be diagnosed with specific tests and responds to antibiotics.

Most adrenal cortex tumors are benign and non-secreting, but proper diagnosis and treatment are important due to the rare possibility of cancer.

Breast cancer treatments work better with AR activation, improving results and reducing side effects.

New treatments for advanced skin cancer are improving patient outcomes, but drug resistance and finding the right treatment combinations are still big challenges.

Janus kinase inhibitors are effective and generally safe for treating hair loss in adults with alopecia areata.

Topical rosuvastatin and melatonin creams significantly reduce psoriasis severity and are safe.

In June 2019, the stem cell research field saw major progress, including new clinical trials, FDA approvals, and industry collaborations.

Lactic acid cream can help improve skin bumps known as eruptive vellus hair cysts.

Adalimumab is the most effective treatment for severe hidradenitis suppurativa, but more research is needed to improve treatment options.

New treatments for hair loss show promise, but more research is needed to confirm their safety and effectiveness.

Skin reactions from cancer treatments might predict how well the treatments work.

Dermatoscopy and videodermatoscopy are useful and reliable for tracking treatment progress in various skin conditions.

Nonsteroid treatments for alopecia areata show promise but need more high-quality research.

Hair loss is common in autoimmune diseases and can be an early sign of the condition, often requiring prompt treatment to prevent permanent damage.

The drug IPI-926 is safe at 160 mg daily and may help treat certain tumors, especially basal cell carcinoma.

The Li-Pa/Ca and Do/Ca chemotherapy regimens for serous ovarian cancer showed better short-term and long-term results than the Pa/Ca regimen.

Some lung cancer patients treated with EGFR inhibitors may develop a hair loss condition similar to folliculitis decalvans.

Ripretinib is effective and safe for treating advanced GIST in Chinese patients, particularly for non-gastric GISTs.

PRP treatments and hair transplantation may be linked to the progression of pseudolymphoma to lymphoma.

Dutasteride is effective for treating prostate enlargement and reducing related surgery risk, but is not approved for preventing prostate cancer.

Low-dose chemotherapy is safer, more effective, and cost-effective than surgery for treating bone lesions in children.

Light/laser therapy can effectively increase hair density in some types of alopecia, especially androgenic alopecia and alopecia areata.

Drugmakers are optimistic about targeting the Wnt pathway for new treatments despite past challenges.

Finasteride significantly increases scalp hair and prevents hair loss in young and middle-aged men.

Red clover extract-based scalp treatments significantly improved hair volume and reduced hair loss and damage.

Lasers and energy-assisted methods show promise for treating hair loss, but more research is needed.

Non-scarring alopecia in females affects emotional well-being and requires accurate diagnosis and personalized treatment.

Tofacitinib and adalimumab are promising treatments for cicatricial alopecia with few side effects.